20000224

N

T185

1

20000224

A

Creation of a better medication safety culture in Europe: Building up safe medication practices Expert Group on Safe Medication Practices (2006). Guideline on good pharmacovigilance practices (GVP). Module VI -Management and reporting of adverse reactions to medicinal products.Center for Drug Evaluation and Research (CDER), the Division of Medication Error Prevention and Analysis (DMEPA): http://www.fda.gov/drugs/drugsafety/medicationerrors/. Guidance for Industry. Safety Considerations for Product Design to Minimize Medication Errors. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research December 2012 Drug Safety. European Medicine Agency: Medication errors. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/gener al/general_content_000570.jsp. Health Canada's role in the Management and Prevention of Harmful Medication Incidents. http://www.hc-sc.gc.ca/dhp-mps/medeff/cmirps- scdpim-eng.php#a1. National Coordinating Council for Medication Error Reporting and Prevention (US); 2001. About medication errors. https://www.nccmerp.org/about-medication-errors. Accessed December 1, 2017.

C4087540

See more